C-EOHUGero
physics-informed AI, aging biology, therapeutics
discoverydiscoveringbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-EOHU
C-EOHUC-EOHUphysics-informed AI, aging biology, therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Gero physics-informed AI, aging biology, therapeutics
Gero is a therapeutics company working at the intersection of theoretical physics, biology, and generative AI. Its platform uses more than 100M longitudinal medical records to model aging trajectories and separate irreversible aging from reversible disease processes. The company aims to discover targets and design medicines that restore resilience, delay age-related disease, and extend human healthspan.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Gero — Early mechanism · Lower middle. Derived deterministically from 12 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic